바이오인

1. 기술 개요 ······················································1
가. 정의 및 특징 ····················································1
나. 면역조절치료제의 기술 개요 및 기술 분류 ···························2
1) 사이토카인(Cytokine) ···········································2
2) 백신(Vaccine) ·················································3
3) 면역증강제(Immunostimulants) ··································5
4) 면역억제제(Immunosuppressants) ·······························6
2. 서지분석 ·······················································8
가. 특허 및 논문분석을 위한 기술 분류 체계 및 검색 범위 ················8
1) 특허검색 조건 ··················································8
나. 특허분석 ·······················································9
1) 특허로 살펴본 면역조절치료제 세계 동향 ··························9
2) 특허로 살펴본 면역조절치료제 국내 동향 ·························12
다. 논문분석 ······················································14
1) 논문으로 살펴본 면역조절치료제 세계 동향 ·······················14
2) 논문으로 살펴본 면역조절치료제 국내 동향 ·······················16
라. 시장성 분석․관련 산업 동향 ·····································17
3. 기술 개발동향 ················································21
가. 세계동향 ·······················································21
1) 총괄 국외 기술 발전도 ·········································21
2) 해외 연구개발 동향 ············································22
3) 주요 연구자 ··················································23
4) 주요 기업 ····················································25
- ii -
나. 국내동향 ······················································28
1) 총괄 국외 기술 발전도 ·········································28
2) 관련수행과제 ·················································29
3) 국내 주요 연구자 ·············································29
4. 국내외 기술 수준 비교 ·······································34
가. 기술수준 비교 ·································································································· 34
나. SWOT 분석 ···················································35
5. 기대효과 ······················································36
가. 기술적 효과 ······································································································ 36
나. 경제․산업적 효과 ··············································36
6. 참고문헌 ······················································37
별첨 1. 단백질 칩 특허분석
별첨 2. 단백질 칩 논문분석